Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2023

06.01.2023 | Original Article

To Determine the Prevalence of Laryngopharyngeal Reflux in Patients of Various Throat Disorders and to Evaluate the Efficacy of Anti-reflux Therapy

verfasst von: Anna Singh, Sangeeta Varty, M. V. Kirtane, Amitav Shukla, Annanya Soni

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

To study the prevalence of Laryngopharyngeal reflux in individuals having throat complaints by applying the Reflux Symptom Index and Reflux finding score as a prognostic tool after anti reflux therapy. Materials and Methods: A Cross-sectional study of 75 patients of age 18 years and above with clinical diagnosis of Laryngopharyngeal reflux was conducted in ENT. Cases were examined with detailed history and thorough examination with indirect laryngoscopy and Hopkins 70 degree endoscope. Symptoms and findings of patients were assessed by Belafsky Reflux Symptom Index and Reflux Finding Score. Patients presenting Belafsky Reflux Symptom Index > 13 and also Reflux Finding Score > 7 were classified as having Laryngopharyngeal reflux. After 6 weeks of treatment, patients were reassessed and Reflux Symptom Index and Reflux finding score were calculated. Results: The mean age of the study subjects was 37.12 ± 12.39 years. Most common symptom reported based on RSI questionnaire was excessive throat mucus (81.33%) followed by clearing of throat (75%) and coughing on lying down and heartburn. Based on the Laryngoscopy, about 57.33% had thick endolarygeal mucus, 56% had diffuse erythema, 45.33% had granulations and 29.33% had subglottic edema. Based on the reflux symptom scores, we found 53.33% and 80% of patients based on reflux findings score to have Laryngopharyngeal Reflux. The mean Reflux Symptom Index scores were 16.25 ± 5.53 and 10.73 ± 4.40 and also the mean Reflux Finding scores were 13.81 ± 2.42 and 6.61 ± 2.16 respectively before and after the treatment which was statistically significant.
Literatur
1.
Zurück zum Zitat Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294(12):1534–1540CrossRefPubMed Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294(12):1534–1540CrossRefPubMed
2.
Zurück zum Zitat Connor NP, Palazzi-Churas KLP, Cohen SB, Leverson GE, Bless DM (2007) Symptoms of extraesophageal reflux in a community-dwelling sample. J Voice 21(2):189–202CrossRefPubMed Connor NP, Palazzi-Churas KLP, Cohen SB, Leverson GE, Bless DM (2007) Symptoms of extraesophageal reflux in a community-dwelling sample. J Voice 21(2):189–202CrossRefPubMed
3.
Zurück zum Zitat Ing AJ, Ngu MC, Breslin AB (1994) Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 149(1):160–167CrossRefPubMed Ing AJ, Ngu MC, Breslin AB (1994) Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 149(1):160–167CrossRefPubMed
4.
Zurück zum Zitat Kahrilas PJ (2010) Chronic cough and gastroesophageal reflux disease: new twists to the riddle. Gastroenterology 139(3):716–718CrossRefPubMed Kahrilas PJ (2010) Chronic cough and gastroesophageal reflux disease: new twists to the riddle. Gastroenterology 139(3):716–718CrossRefPubMed
5.
Zurück zum Zitat Adhami T, Goldblum JR, Richter JE, Vaezi MF (2004) The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 99(11):2098–2106CrossRefPubMed Adhami T, Goldblum JR, Richter JE, Vaezi MF (2004) The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 99(11):2098–2106CrossRefPubMed
6.
Zurück zum Zitat Vaezi MF (2003) Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence. Am J Med 115:97–104CrossRef Vaezi MF (2003) Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence. Am J Med 115:97–104CrossRef
7.
Zurück zum Zitat Toohill RJ, Kuhn JC (1997) Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Med 103(5):100–106CrossRef Toohill RJ, Kuhn JC (1997) Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Med 103(5):100–106CrossRef
8.
Zurück zum Zitat Kondo Y, Ogasawara N, Sasaki M, Arimoto M, Yanamoto K, Nishimura K et al (2013) Edema of the interarytenoid mucosa seen on endoscopy is related to endoscopic-positive esophagitis (EE) and is an independent predictor of EE. Dig Endosc 25(6):578–584CrossRefPubMed Kondo Y, Ogasawara N, Sasaki M, Arimoto M, Yanamoto K, Nishimura K et al (2013) Edema of the interarytenoid mucosa seen on endoscopy is related to endoscopic-positive esophagitis (EE) and is an independent predictor of EE. Dig Endosc 25(6):578–584CrossRefPubMed
9.
Zurück zum Zitat Lieder A, Issing W (2011) Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon(R) Advance: how we do it. Clin Otolaryngol 36(6):583–587CrossRefPubMed Lieder A, Issing W (2011) Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon(R) Advance: how we do it. Clin Otolaryngol 36(6):583–587CrossRefPubMed
10.
Zurück zum Zitat Koufman JA, Amin MR, Panetti M (2000) Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 123(4):385–388CrossRefPubMed Koufman JA, Amin MR, Panetti M (2000) Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 123(4):385–388CrossRefPubMed
11.
Zurück zum Zitat Mattoo O, Muzaffar R, Mir A, Yousuf A, Hamid Charag A, Ahmad R (2012) Laryngopharyngeal reflux: prospective study analyzing various nonsurgical treatment modalities for LPR. Int J Phonosurg Laryngol 2:5–8 CrossRef Mattoo O, Muzaffar R, Mir A, Yousuf A, Hamid Charag A, Ahmad R (2012) Laryngopharyngeal reflux: prospective study analyzing various nonsurgical treatment modalities for LPR. Int J Phonosurg Laryngol 2:5–8 CrossRef
12.
13.
Zurück zum Zitat Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American academy of otolaryngology-head and neck surgery. Otolaryngol neck Surg 127(1):32–35CrossRef Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American academy of otolaryngology-head and neck surgery. Otolaryngol neck Surg 127(1):32–35CrossRef
14.
Zurück zum Zitat Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J (2004) Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 114(12):2129–2134CrossRefPubMed Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J (2004) Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 114(12):2129–2134CrossRefPubMed
15.
Zurück zum Zitat De BN, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B et al (2012) How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related ? World J Gastroenterol 18(32):4363–4370CrossRef De BN, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B et al (2012) How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related ? World J Gastroenterol 18(32):4363–4370CrossRef
16.
Zurück zum Zitat Patigaroo SA, Dar NH, Shafi OM, Qazi SM (2019) Treating laryngopharyngeal reflux with proton-pump inhibitors—an observational study. Int J Med Sci Public Heal 8(2):150–155 Patigaroo SA, Dar NH, Shafi OM, Qazi SM (2019) Treating laryngopharyngeal reflux with proton-pump inhibitors—an observational study. Int J Med Sci Public Heal 8(2):150–155
17.
Zurück zum Zitat Ezzeldin H, Hasseba AA (2015) Effect of proton pump inhibitor and voice therapy on reflux-related laryngeal disorders. Tanta Med J 43:127–133CrossRef Ezzeldin H, Hasseba AA (2015) Effect of proton pump inhibitor and voice therapy on reflux-related laryngeal disorders. Tanta Med J 43:127–133CrossRef
18.
Zurück zum Zitat Rafii B, Taliercio S, Achlatis S, Ruiz R, Amin MR, Branski RC (2014) Incidence of underlying laryngeal pathology in patients initially diagnosed with laryngopharyngeal reflux. Laryngoscope 124:1420–1424CrossRefPubMed Rafii B, Taliercio S, Achlatis S, Ruiz R, Amin MR, Branski RC (2014) Incidence of underlying laryngeal pathology in patients initially diagnosed with laryngopharyngeal reflux. Laryngoscope 124:1420–1424CrossRefPubMed
19.
Zurück zum Zitat Park JH, Lee DH, Kim JY, Park SY, Yoon H, Park YS et al (2012) Gastroesophageal reflux disease with laryngopharyngeal manifestation in Korea. Hepatogastroenterology 59(120):2527–2529PubMed Park JH, Lee DH, Kim JY, Park SY, Yoon H, Park YS et al (2012) Gastroesophageal reflux disease with laryngopharyngeal manifestation in Korea. Hepatogastroenterology 59(120):2527–2529PubMed
20.
Zurück zum Zitat Elmonem MA, El A, Kamal A, Gad A (2012) Prevalence of laryngeopharygeal reflux among GERD patients. AAMJ 10(3):1–17 Elmonem MA, El A, Kamal A, Gad A (2012) Prevalence of laryngeopharygeal reflux among GERD patients. AAMJ 10(3):1–17
21.
Zurück zum Zitat Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C et al (2005) Laryngopharyngeal reflux : prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115:1230–1238CrossRefPubMed Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C et al (2005) Laryngopharyngeal reflux : prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115:1230–1238CrossRefPubMed
Metadaten
Titel
To Determine the Prevalence of Laryngopharyngeal Reflux in Patients of Various Throat Disorders and to Evaluate the Efficacy of Anti-reflux Therapy
verfasst von
Anna Singh
Sangeeta Varty
M. V. Kirtane
Amitav Shukla
Annanya Soni
Publikationsdatum
06.01.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 2/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-022-03273-0

Weitere Artikel der Ausgabe 2/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2023 Zur Ausgabe

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.